Evidence map›Paper›PMID 38386711›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

OCA-B/Pou2af1 is sufficient to promote CD4

Wenxiang Sun, Erik P Hughes, Heejoo Kim, Jelena Perovanovic, Krystal R Charley, Bryant Perkins, Junhong Du, Andrea Ibarra, Amber R Syage, J Scott Hale and 2 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Wenxiang Sun *Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112.
Erik P Hughes *Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112.ORCID 0000-0001-8672-3928
Heejoo Kim *Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112.
Jelena PerovanovicDepartment of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112.
Krystal R CharleyDepartment of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112.
Bryant PerkinsDepartment of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112.
Junhong DuDepartment of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112.
Andrea IbarraDepartment of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112.
Amber R SyageDepartment of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112.
J Scott HaleDepartment of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112.
Matthew A WilliamsDepartment of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112.ORCID 0000-0002-4721-4482
Dean TantinDepartment of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84112.ORCID 0000-0003-1354-8385
University of Utah · US

Funding

Role of Transcription Coactivator OCA-B in Gene Poising and Immunological MemoryR01AI100873 · NIAID · UNIVERSITY OF UTAH · PI TANTIN, DEAN · 2013 to 2022
$3.8M
TCR-dependent activation, functional differentiation and memory formation of CD4+ T cells following infectionR01AI137248 · NIAID · UNIVERSITY OF UTAH · PI WILLIAMS, MATTHEW A · 2018 to 2022
$2.5M
Targeting OCA-B in multiple sclerosisR01AI162929 · NIAID · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI DEAN TANTIN · 2022 to 2026
$2.0M
Cross-disciplinary Training in Immunology, Inflammation and Infectious DiseaseT32AI138945 · NIAID · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Tracey Jane Lamb, Matthew A Williams · 2018 to 2026
$1.6M
The Neuroimmunology Training Program at the University of UtahT32NS115664 · NINDS · UNIVERSITY OF UTAH · PI O'CONNELL, RYAN M, WILCOX, KAREN S · 2020 to 2024
$988k
NIAID NIH HHS R01 AI100873NIAID NIH HHS R01 AI137248NIAID NIH HHS R01 AI162929NIAID NIH HHS T32 AI138945NINDS NIH HHS T32 NS115664
6 · The paper itself

Abstract

The molecular mechanisms leading to the establishment of immunological memory are inadequately understood, limiting the development of effective vaccines and durable antitumor immune therapies. Here, we show that ectopic OCA-B expression is sufficient to improve antiviral memory recall responses, while having minimal effects on primary effector responses. At peak viral response, short-lived effector T cell populations are expanded but show increased

Indexed as

CD4-Positive T-LymphocytesMemory T CellsAnimalsAntigens, DifferentiationGADD45 ProteinsImmunologic MemoryMemoryMiceReceptors, Interleukin-7Trans-ActivatorsAntigens, DifferentiationGadd45b protein, mouseGADD45 ProteinsPou2af1 protein, mouseReceptors, Interleukin-7Trans-ActivatorsCD4 T cellsimmunological memoryPou2af1/OCA-B

Identifiers

PMID38386711
PMCPMC10907311
OpenAlexW4392028262

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.